Clinical Trial Update: Analysis of Volatile Organic Compounds in the Breath of Lung Transplant Rejection Patients Using Infrared Spectroscopy

View source ↗

Summary

Clinical trial update on a terminated study evaluating volatile organic compounds in breath, using infrared spectroscopy, to detect lung transplant rejection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Transplant Rejection

Snippet

Sponsor: Paragonix Technologies | Conditions: Lung Transplant Rejection | Status: TERMINATED